.jpg)
STAT+: Pharmalittle: Fauci unconvinced Omicron-specific vaccines are needed; J&J rebuffed warnings about a diabetes drug
And so, another working week will soon draw to a close. Not a moment too…
Category: Biotech
STAT+: ‘All I want for Christmas’ is higher prices: Congressional report accuses pharma of manipulating Americans for profit
It was the day before Christmas in 2015 and a senior director of national accounts…
Opinion: STAT+: Maintaining trust in science is crucial to public health. Here’s how the biopharma industry can help
Against declining trust in traditional news sources and institutions that provide data and information, the…
Opinion: Forensic medical examinations are key to helping asylum seekers prove trauma
After a decade of horrific abuse by her husband, Ms. A. felt she had no…
.jpg)
Opinion: Vaccine skepticism is healthy. Cynicism is not
Misinformation is tightening its stranglehold on the American psyche. My 9-year-old daughter, Sonia, knows no…
Fauci says Omicron-specific version of Covid-19 vaccines may not be necessary
Anthony Fauci isn’t convinced Covid-19 vaccine manufacturers are going to need to produce an Omicron-specific…
The Omicron variant can likely outcompete Delta — and that could worsen the U.S. Covid-19 epidemic
As the Omicron variant snowballs in South Africa and widens its inroads in Europe, evidence…
Listen: Biogen, Biogen, Biogen, with a dash of Omicron
How did the Aduhelm debacle push Biogen to the brink? And what’s the latest on…
STAT+: Hospital, physician lobbies sue Biden administration over surprise billing regulation
WASHINGTON — The nation’s largest hospital and physician lobbying groups are suing the Biden administration…
Opinion: The U.S. is at a Kasserine Pass moment for Covid leaders
In the military, as in business and civilian life, leadership change can be needed to…
FDA expands authorization for Pfizer’s Covid-19 booster to cover 16- and 17-year-olds
The Food and Drug Administration on Thursday expanded the emergency use authorization for Pfizer and…
Digital pills for PrEP & Holmes testimony on Theranos comes to a close
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Pharmalittle: Biotech VC firms charge their startups ‘consulting’ fees; FDA authorizes preventive Covid antibody cocktail
Hello, everyone, and how are you today? We are doing just fine, thank you. After…
Opinion: Vaccine equity is essential. Vaccine makers need to drop barriers to reaching refugees and other displaced people
National-level Covid-19 vaccination figures can tell a lot about how the battle against the pandemic…
Opinion: Gatekeepers need to tame ‘Wild West’ of mental health and other digital health therapeutics
From individuals to employers, there’s growing interest in using digital services to help people work…
A decade without data: Eating disorder researchers say a gap in CDC survey has left them flying blind
Eating disorders among youth have been on the rise since the pandemic started — adolescent…
STAT+: At biotech venture capital firms, collecting ‘consulting fees’ from startups has become widespread
Some of the biggest names in biotech venture capital have charged their startups millions of…
Take a deep breath: Asthma drug study failed to include Black and Puerto Rican children who could benefit most
If a drug maker tested an asthma treatment in children and found it significantly reduced…
STAT+: AbbVie unit to pay $200 million to resolve closely watched opioid lawsuit in New York
Allergan, which is a unit of AbbVie (ABBV) agreed to pay up to $200 million…
Opinion: Ending the pandemic requires global solidarity, not blame
When historians write about the Covid-19 pandemic, they will certainly highlight the essential research behind…
Pfizer’s vaccine chief on Omicron, mix-and-match boosters, and being prepared for the unknown
Pfizer and partner BioNTech announced Wednesday that new data show that antibodies generated by their…
In Minneapolis, home to George Floyd, heavy policing is tied to higher rates of preterm births
The longstanding toll of police violence on Black communities came into sharp relief last year…
STAT+: In the blood of marathoning mice, scientists find clues to how exercise benefits the brain
If you give a mouse a wheel, it will run, and run, and run: between…
In a merger of opposites, City of Hope to buy Cancer Treatment Centers of America for $390 million
City of Hope, the Los Angeles-based nonprofit hospital system, said Wednesday that it will purchase…
STAT+: Pharmalittle: Biogen prepares for large layoffs; Pfizer Covid booster neutralized Omicron but variant may elude two doses
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
Pfizer-BioNTech Covid-19 shot loses power against Omicron variant, but booster restores protection
People who have received two doses of the Pfizer-BioNTech Covid-19 vaccine are likely susceptible to…
Opinion: Listen: A public health expert passes on football’s full body collisions for youth
If there was one moment that led Kathleen Bachynski to a career studying the public…
Opinion: Archaic in-person exam for digital prescribing is holding back health care innovation
At a press conference in 1986, President Ronald Reagan said he felt the nine most…
Changing the definition of ‘fully vaccinated’ is more than just semantics, experts argue
Who’s “fully vaccinated” against Covid-19 — and who’s not — is starting to get a…
STAT+: Biogen’s reckoning: How the Aduhelm debacle pushed a troubled company and its fractured leadership to the brink
The shocking revelation came in a Saturday afternoon email, restricted to a tight circle of…
A first, small study suggests Omicron is a larger threat to Covid-19 immunity than other variants
A small, preliminary study has found a significant drop in how well vaccine-elicited antibodies target…
STAT+: Martin Shkreli’s former company pays $40 million for blocking competition for a life-saving drug
Six years after a national scandal erupted, a group of federal and state authorities have…
STAT+: Centene agrees to pay $28 million to resolve another state probe into its PBM business
Centene (CNC), one of the largest health insurers in the U.S., agreed to pay nearly…
Pear makes it stock market debut & telehealth players lock arms
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: ‘A multi-decade journey’: Chan Zuckerberg Initiative invests another $3.4 billion to advance scientific tools
As Mark Zuckerberg aims to build his social network empire into the foundation for a…
STAT+: Pharmalittle: Glaxo and Vir antibody remains effective against Omicron; Biden talks up drug-pricing reform
Top of the morning to you, and a fine one it is. Sunny skies and…
STAT+: STAT+ Conversation: The ‘Shroom Boom’
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET. Every…
Is cancer biology research reproducible? After a decade of work, the answer still isn’t clear
Replication is something of a litmus test for scientific truth, and cancer biologists at the…
Opinion: Stopping the spread of mass hysteria by Facebook, other social media platforms
How are angry mobs storming the Capitol and Facebook driving our daughters to bulimia related?…
Opinion: Labels can harm, but they also can help: See ‘profound autism’
Labels are a divisive subject. When used inappropriately, they have the power to misrepresent and…
STAT+: Carbon Health launches a program for continuous glucose monitoring to curb diabetes risk
In April, endocrinologist Calvin Wu described how his company, Steady Health, was making use of…
STAT+: Major telehealth players unite ahead of tough lobbying battle
WASHINGTON — Major players in the telehealth space have united to create a supergroup of…
Growing use of home Covid-19 tests leaves health agencies in the dark about unreported cases
When fans of the band Phish started falling ill with Covid-19 all over the country…
STAT+: Flagship to launch a new startup focused on neurodegenerative conditions, including Parkinson’s
Flagship Pioneering is gearing up to launch a new company that seems to be developing…
STAT+: Targeting prices for accelerated approval drugs may have limited impact on overall drug spending
As U.S. regulators approve more medicines under the accelerated approval pathway, Medicare and Medicaid continue…
STAT+: Acadia drug meets endpoints for treating Rett syndrome, a rare neurological disease
An experimental drug being developed by Acadia Pharmaceuticals improved the symptoms of women and girls…
STAT+: As Biden touts his effort to cap insulin prices, advocates push for an even more ambitious reform
WASHINGTON — President Biden promised Monday that Democrats’ signature drug pricing plan will mean no…
Salary gap between male and female physicians adds up to $2 million in lifetime earnings
Women may now equal or outnumber men in medical school classes, but their lifetime earnings…
STAT+: An advocacy group seeks to broaden access to a Pfizer Covid-19 pill
In a bid to expand access to the Pfizer (PFE) Covid-19 pill, an advocacy group…
Opinion: Solving the U.S. drug pricing crisis starts with a crucial confirmation hearing
The Senate began its confirmation hearing last week for President Biden’s nominee to head the…